These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16855848)

  • 1. The two novel CETP mutations Gln87X and Gln165X in a compound heterozygous state are associated with marked hyperalphalipoproteinemia and absence of significant coronary artery disease.
    Rhyne J; Ryan MJ; White C; Chimonas T; Miller M
    J Mol Med (Berl); 2006 Aug; 84(8):647-50. PubMed ID: 16855848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are human CETP mutations and CETP-inhibiting drugs a good or a bad deal?
    Luft FC
    J Mol Med (Berl); 2006 Aug; 84(8):625-7. PubMed ID: 16855847
    [No Abstract]   [Full Text] [Related]  

  • 3. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
    Kimura H; Miyazaki R; Imura T; Masunaga S; Shimada A; Mikami D; Kasuno K; Takahashi N; Hirano T; Yoshida H
    Nephrology (Carlton); 2011 Aug; 16(6):558-66. PubMed ID: 21352420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutations of CETP gene in Italian subjects with hyperalphalipoproteinemia.
    Cefalù AB; Noto D; Magnolo L; Pinotti E; Gomaraschi M; Martini S; Vigna GB; Calabresi L; Tarugi P; Averna MR
    Atherosclerosis; 2009 May; 204(1):202-7. PubMed ID: 18926541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians.
    van der Steeg WA; Hovingh GK; Klerkx AH; Hutten BA; Nootenboom IC; Levels JH; van Tol A; Dallinga-Thie GM; Zwinderman AH; Kastelein JJ; Kuivenhoven JA
    J Lipid Res; 2007 Mar; 48(3):674-82. PubMed ID: 17192423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.
    Inazu A; Brown ML; Hesler CB; Agellon LB; Koizumi J; Takata K; Maruhama Y; Mabuchi H; Tall AR
    N Engl J Med; 1990 Nov; 323(18):1234-8. PubMed ID: 2215607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese.
    Nagano M; Yamashita S; Hirano K; Takano M; Maruyama T; Ishihara M; Sagehashi Y; Kujiraoka T; Tanaka K; Hattori H; Sakai N; Nakajima N; Egashira T; Matsuzawa Y
    J Atheroscler Thromb; 2004; 11(3):110-21. PubMed ID: 15256762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particle size analysis of high density lipoproteins in patients with genetic cholesteryl ester transfer protein deficiency.
    Arai T; Tsukada T; Murase T; Matsumoto K
    Clin Chim Acta; 2000 Nov; 301(1-2):103-17. PubMed ID: 11020466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia.
    Yamashita S; Maruyama T; Hirano K; Sakai N; Nakajima N; Matsuzawa Y
    Atherosclerosis; 2000 Oct; 152(2):271-85. PubMed ID: 10998455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
    Tanrikulu S; Ademoglu E; Gurdol F; Mutlu-Turkoglu U; Bilge AK; Nisanci Y
    Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations of cholesteryl ester transfer protein (CETP) gene in Japanese hyperalphalipoproteinemic subjects.
    Ohtani R; Inazu A; Noji Y; Wakasugi T; Miwa K; Tada H; Kawashiri MA; Noguchi T; Nohara A; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H
    Clin Chim Acta; 2012 Mar; 413(5-6):537-43. PubMed ID: 22122993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound heterozygote of cholesteryl-ester transfer protein deficiency in a patient with hyperalphalipoproteinemia.
    Takegoshi T; Haba T; Kitoh C; Inazu A; Koizumi J; Mabuchi H; Takeda R
    Atherosclerosis; 1992 Sep; 96(1):83-5. PubMed ID: 1418105
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholesteryl ester transfer protein deficiency caused by a nonsense mutation detected in the patient's macrophage mRNA.
    Gotoda T; Kinoshita M; Shimano H; Harada K; Shimada M; Ohsuga J; Teramoto T; Yazaki Y; Yamada N
    Biochem Biophys Res Commun; 1993 Jul; 194(1):519-24. PubMed ID: 8333866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population--relation between the mutation and hyperalphalipoproteinemia.
    Hirano K; Yamashita S; Funahashi T; Sakai N; Menju M; Ishigami M; Hiraoka H; Kameda-Takemura K; Tokunaga K; Hoshino T
    Atherosclerosis; 1993 Apr; 100(1):85-90. PubMed ID: 8318066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader assay.
    Nagano M; Yamashita S; Hirano K; Ito M; Maruyama T; Ishihara M; Sagehashi Y; Oka T; Kujiraoka T; Hattori H; Nakajima N; Egashira T; Kondo M; Sakai N; Matsuzawa Y
    J Lipid Res; 2002 Jul; 43(7):1011-8. PubMed ID: 12091484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TaqIB and severity of coronary artery disease in the Turkish population: a pilot study.
    Kaman D; İlhan N; İlhan N; Akbulut M
    Bosn J Basic Med Sci; 2015 Feb; 15(1):9-13. PubMed ID: 25725138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia.
    Maruyama T; Sakai N; Ishigami M; Hirano K; Arai T; Okada S; Okuda E; Ohya A; Nakajima N; Kadowaki K; Fushimi E; Yamashita S; Matsuzawa Y
    Atherosclerosis; 2003 Jan; 166(1):177-85. PubMed ID: 12482565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid and apoprotein composition of HDL in partial or complete CETP deficiency.
    Niesor EJ; von der Mark E; Calabresi L; Averna M; Cefalù AB; Tarugi P; Nilsson P; Dernick G
    Curr Vasc Pharmacol; 2012 Jul; 10(4):422-31. PubMed ID: 22339301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher frequency of abnormal serum angiopoietin-like protein 3 than abnormal cholesteryl ester transfer protein in Japanese hyperalphalipoproteinemic subjects.
    Moon HD; Nakajima K; Kamiyama K; Takanashi K; Sakurabayashi I; Nagamine T
    Clin Chim Acta; 2008 Dec; 398(1-2):99-104. PubMed ID: 18804459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.